Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Assets (QoQ)Assets Growth (1y)Assets Growth (3y)Assets Growth (5y)Capital Expenditures (QoQ)Capital Expenditures Growth (1y)Capital Expenditures Growth (3y)Capital Expenditures Growth (5y)Cash & Equivalents (QoQ)Cash & Equivalents Growth (1y)Cash & Equivalents Growth (3y)Cash & Equivalents Growth (5y)Cash from Investing Activities (QoQ)Cash from Investing Activities Growth (1y)Cash from Investing Activities Growth (3y)Cash from Investing Activities Growth (5y)Cash from Operations (QoQ)Cash from Operations Growth (1y)Cash from Operations Growth (3y)Cash from Operations Growth (5y)EBIT (QoQ)EBIT Growth (1y)EBIT Growth (3y)EBIT Growth (5y)EBIT Margin (QoQ)EBIT Margin Growth (1y)EBIT Margin Growth (3y)EBIT Margin Growth (5y)EBITDA Margin (QoQ)EBITDA Margin Growth (1y)EBITDA Margin Growth (3y)EBITDA Margin Growth (5y)EBT (QoQ)EBT Growth (1y)EBT Growth (3y)EBT Growth (5y)EBT Margin (QoQ)EBT Margin Growth (1y)EBT Margin Growth (3y)EBT Margin Growth (5y)EPS (Basic) (QoQ)EPS (Basic) Growth (1y)EPS (Basic) Growth (3y)EPS (Basic) Growth (5y)EPS (Weighted Average and Diluted) (QoQ)EPS (Weighted Average and Diluted) Growth (1y)EPS (Weighted Average and Diluted) Growth (3y)EPS (Weighted Average and Diluted) Growth (5y)Enterprise Value (QoQ)Enterprise Value Growth (1y)Enterprise Value Growth (3y)Enterprise Value Growth (5y)FCF Margin (QoQ)FCF Margin Growth (1y)FCF Margin Growth (3y)FCF Margin Growth (5y)Free Cash Flow (QoQ)Free Cash Flow Growth (1y)Free Cash Flow Growth (3y)Free Cash Flow Growth (5y)Gross Margin (QoQ)Gross Margin Growth (1y)Gross Margin Growth (3y)Gross Margin Growth (5y)Gross Profit (QoQ)Gross Profit Growth (1y)Gross Profit Growth (3y)Gross Profit Growth (5y)Net Cash Flow (QoQ)Net Cash Flow Growth (1y)Net Cash Flow Growth (3y)Net Cash Flow Growth (5y)Net Income (QoQ)Net Income Growth (1y)Net Income Growth (3y)Net Income Growth (5y)Net Income towards Common Stockholders (QoQ)Net Income towards Common Stockholders Growth (1y)Net Income towards Common Stockholders Growth (3y)Net Income towards Common Stockholders Growth (5y)Net Margin (QoQ)Net Margin Growth (1y)Net Margin Growth (3y)Net Margin Growth (5y)Operating Income (QoQ)Operating Income Growth (1y)Operating Income Growth (3y)Operating Income Growth (5y)Operating Margin (QoQ)Operating Margin Growth (1y)Operating Margin Growth (3y)Operating Margin Growth (5y)Profit After Tax (QoQ)Profit After Tax Growth (1y)Profit After Tax Growth (3y)Profit After Tax Growth (5y)Property, Plant & Equipment (Net) (QoQ)Property, Plant & Equipment (Net) Growth (1y)Property, Plant & Equipment (Net) Growth (3y)Property, Plant & Equipment (Net) Growth (5y)Return on Capital Employed (QoQ)Return on Capital Employed Growth (1y)Return on Capital Employed Growth (3y)Return on Capital Employed Growth (5y)Return on Equity Growth (3y)Return on Equity Growth (5y)Return on Invested Capital Growth (3y)Return on Invested Capital Growth (5y)Revenue (QoQ)Revenue Growth (1y)Revenue Growth (3y)Revenue Growth (5y)Share-based Compensation (QoQ)Share-based Compensation Growth (1y)Share-based Compensation Growth (3y)Share-based Compensation Growth (5y)Shareholder's Equity (QoQ)Shareholder's Equity Growth (1y)Shareholder's Equity Growth (3y)Shareholder's Equity Growth (5y)Tax Rate (QoQ)Tax Rate Growth (1y)Tax Rate Growth (3y)Tax Rate Growth (5y)Total Debt (QoQ)Total Debt Growth (1y)Total Debt Growth (3y)Total Debt Growth (5y)
Income Statement
Others
Ratios

Mimedx (MDXG) EPS (Basic) (QoQ) (2011 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Quantum Biopharma 961,148.99 Bn 961,148.98 Bn -
2 Alterity Therapeutics 744,933.29 Bn 744,933.26 Bn -
3 Legend Biotech 2,540.00 Bn 2,539.71 Bn 242.10 Mn
4 Nanobiotix 2,199.85 Bn 2,199.78 Bn -
5 Akari Therapeutics 1,635.88 Bn 1,635.88 Bn -
6 Vertex Pharmaceuticals 111.32 Bn 104.07 Bn 2.59 Bn
7 Evaxion A 62.56 Bn 62.54 Bn -
8 Regeneron Pharmaceuticals 62.55 Bn 53.79 Bn 3.31 Bn
9 Alnylam Pharmaceuticals 39.57 Bn 36.56 Bn 959.66 Mn
10 Mimedx 530.69 Mn 370.92 Mn 41.62 Mn

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 -170.00%
Dec 31, 2025 -9.09%
Sep 30, 2025 57.14%
Jun 30, 2025 40.00%
Mar 31, 2025 0.00%
Dec 31, 2024 0.00%
Sep 30, 2024 -58.33%
Jun 30, 2024 100.00%
Mar 31, 2024 -84.62%
Dec 31, 2023 550.00%
Sep 30, 2023 -14.29%
Jun 30, 2023 333.33%
Mar 31, 2023 -50.00%
Dec 31, 2022 77.78%
Sep 30, 2022 18.18%
Jun 30, 2022 0.00%
Mar 31, 2022 -768.30%
Dec 31, 2021 68.33%
Sep 30, 2021 -33.33%
Jun 30, 2021 66.67%
Mar 31, 2021 47.06%
Dec 31, 2020 64.58%
Sep 30, 2020 -500.00%
Jun 30, 2020 -100.00%
Mar 31, 2020 42.86%
Dec 31, 2019 -158.33%
Sep 30, 2019 175.00%
Jun 30, 2019 -33.33%
Mar 31, 2019 64.71%
Dec 31, 2018 -20,134.92%
Sep 30, 2018 -108.40%
Jun 30, 2018 -50.00%
Mar 31, 2018 0.00%
Dec 31, 2017 -90.24%
Sep 30, 2017 310.00%
Jun 30, 2017 66.67%
Mar 31, 2017 20.00%
Dec 31, 2016 66.67%
Sep 30, 2016 50.00%
Jun 30, 2016 100.00%
Mar 31, 2016 -92.31%
Dec 31, 2015 116.67%
Sep 30, 2015 20.00%
Jun 30, 2015 25.00%
Mar 31, 2015 0.00%
Dec 31, 2014 33.33%
Sep 30, 2014 913.52%
Jun 30, 2014 63.12%
Mar 31, 2014 0.00%
Dec 31, 2013 -210.73%
Sep 30, 2013 67.82%
Jun 30, 2013 50.00%
Mar 31, 2013 -100.00%
Dec 31, 2012 80.00%
Sep 30, 2012 -400.00%
Jun 30, 2012 0.00%
Mar 31, 2012 75.00%
Dec 31, 2011 -100.00%
Sep 30, 2011 33.33%
Jun 30, 2011 40.00%